1 week Ago By Defense World Staff
Prudential Financial Inc. reduced its position in shares of Simulations Plus, Inc. (NASDAQ:SLP – Free Report) by 7.
1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,843 shares of the technology company’s stock after selling 1,293 shares during the period. Prudential Financial Inc.
owned 0.08% of Simulations Plus worth $485,000 as of its most recent SEC filing. Several other large investors also recently modified their holdings of SLP.
Jones Financial Companies Lllp boosted its position in Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after acquiring an additional 427 shares in the last quarter.
AlphaQuest LLC lifted its stake in shares of Simulations Plus by 502.9% in the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock valued at $75,000 after purchasing an additional 2,243 shares during the period.
KLP Kapitalforvaltning AS bought a new stake in shares of Simulations Plus during the fourth quarter valued at approximately $86,000. Quantbot Technologies LP grew its stake in Simulations Plus by 191.6% in the fourth quarter.
Quantbot Technologies LP now owns 5,371 shares of the technology company’s stock worth $150,000 after purchasing an additional 3,529 shares during the period. Finally, US Bancorp DE raised its holdings in Simulations Plus by 14.3% in the fourth quarter.
US Bancorp DE now owns 5,687 shares of the technology company’s stock worth $159,000 after purchasing an additional 713 shares in the last quarter. 78.08% of the stock is owned by institutional investors.
Insider Buying and SellingIn other news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.
91, for a total transaction of $678,200.00. Following the completion of the sale, the director now owns 3,402,584 shares of the company’s stock, valued at $115,381,623.
44. This represents a 0.58 % decrease in their position.
The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 19.40% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast GrowthSLP has been the topic of a number of recent research reports. StockNews.com raised shares of Simulations Plus from a “sell” rating to a “hold” rating in a research report on Friday, April 4th.
KeyCorp upped their price objective on shares of Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a report on Friday, January 24th.
Finally, William Blair reiterated an “outperform” rating on shares of Simulations Plus in a report on Wednesday, January 8th. Two investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $49.
40.Check Out Our Latest Research Report on Simulations PlusSimulations Plus Trading Up 5.4 %SLP stock opened at $25.
55 on Thursday. The stock has a market capitalization of $513.35 million, a PE ratio of 63.
88 and a beta of 1.13. The stock’s 50 day simple moving average is $29.
11 and its 200 day simple moving average is $30.05. Simulations Plus, Inc.
has a 12-month low of $23.01 and a 12-month high of $51.22.
Simulations Plus (NASDAQ:SLP – Get Free Report) last released its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.
25 by $0.06. The company had revenue of $22.
43 million during the quarter, compared to the consensus estimate of $21.93 million. Simulations Plus had a return on equity of 6.
84% and a net margin of 10.97%. Simulations Plus’s revenue for the quarter was up 22.
5% on a year-over-year basis. During the same period last year, the company earned $0.20 EPS.
On average, research analysts predict that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.
About Simulations Plus (Free Report)Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured StoriesFive stocks we like better than Simulations PlusComparing and Trading High PE Ratio StocksQuantum Computing: The $6.5 Billion Opportunity You Can’t IgnoreHow Investors Can Identify and Successfully Trade Gap-Down StocksAre Tariffs Threatening Disney’s Comeback Story?What is the Australian Securities Exchange (ASX) Is Alphabet a Generational Buying Opportunity at These Levels?Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc.
(NASDAQ:SLP – Free Report)..
